Christophe Passot Selected Research

Tyrosine Kinase Inhibitors

9/2020

[EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christophe Passot Research Topics

Disease

4	Rheumatoid Arthritis 01/2022 - 11/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 02/2018
2	Crohn Disease (Crohn's Disease) 01/2022 - 10/2016
2	Ankylosing Spondylitis 01/2022 - 10/2016
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 11/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2020
1	Body Weight (Weight, Body) 02/2024
1	Necrosis 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Peritoneal Neoplasms 11/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2020
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019
1	Hemolysis 01/2019
1	Headache (Headaches) 01/2018
1	Neck Pain (Cervicalgia) 01/2018
1	Vomiting 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Meningeal Carcinomatosis 01/2018
1	Nausea 01/2018
1	Chronic Disease (Chronic Diseases) 10/2016
1	Ulcerative Colitis 10/2016
1	Psoriatic Arthritis 10/2016
1	Virus Diseases (Viral Diseases) 05/2015
1	Neoplasms (Cancer) 01/2012
1	Parasitic Diseases (Parasitic Disease) 01/2012

Drug/Important Bio-Agent (IBA)

7	Monoclonal AntibodiesIBA 01/2022 - 11/2015
3	Infliximab (Remicade)FDA Link 01/2022 - 10/2016
2	eculizumab FDA Link 02/2024 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2019
2	AerosolsIBA 01/2021 - 11/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 11/2020
2	Immunoglobulin G (IgG)IBA 01/2017 - 05/2015
1	Cetuximab (Erbitux)FDA Link 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 09/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2020
1	Inosine Triphosphate (ITP)IBA 01/2019
1	RHO(D) antibody (anti-D)IBA 01/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019
1	Rho(D) Immune Globulin (RhoGAM)IBA 01/2019
1	Panitumumab (Vectibix)FDA Link 02/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Rituximab (Mabthera)FDA Link 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2016
1	neonatal Fc receptorIBA 05/2015
1	Alemtuzumab (Campath)FDA Link 01/2012

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2022
1	Drug Therapy (Chemotherapy) 11/2020